G-substrate: The cerebellum and beyond

Progress in Molecular Biology and Translational Science

Volumn 106, Issue , 2012, Pages 381-416

  Endo, Shogo ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Cerebellum; cGMP; cGMP dependent protein kinase; Long term memory; Neuronal plasticity; Neuroprotection; Parkinson's disease; Phosphodiesterase; Protein phosphatase; Purkinje cell; Retinopathy

Indexed keywords

EID: 84857225545     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-396456-4.00004-3     Document Type: Chapter

References (170)

1. J.E. Casnellie, and P. Greengard Guanosine 3′:5′-cyclic monophosphate-dependent phosphorylation of endogenous substrate proteins in membranes of mammalian smooth muscle Proc Natl Acad Sci USA 71 1974 1891 1895
2. H.R. de Jonge Cyclic nucleotide-dependent phosphorylation of intestinal epithelium proteins Nature 262 1976 591 593
3. T.M. Lincoln, C.L. Hall, C.R. Park, and J.D. Corbin Guanosine 3′:5′-cyclic monophosphate binding proteins in rat tissues Proc Natl Acad Sci USA 73 1976 2559 2563
4. U. Walter Distribution of cyclic-GMP-dependent protein kinase in various rat tissues and cell lines determined by a sensitive and specific radioimmunoassay Eur J Biochem 118 1981 339 346 (Pubitemid 11019516)
5. U. Walter, S.M. Lohmann, G. Reiser, G. Schwoch, P. Miller, and P. DeCamilli Studies on regulation and cellular localization of cAMP- and cGMP-dependent protein kinases Prog Clin Biol Res 102 1982 173 182
6. R.B. Pearson, and B.E. Kemp Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations Methods Enzymol 200 1991 62 81
7. X. Wang, and P.J. Robinson Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system J Neurochem 68 1997 443 456 (Pubitemid 27044703)
8. J. Schlossmann, and M. Desch cGK substrates Handb Exp Pharmacol 191 2009 163 193
9. J.A. Beavo, and L.L. Brunton Cyclic nucleotide research - still expanding after half a century Nat Rev Mol Cell Biol 3 2002 710 718 (Pubitemid 34987792)
10. S.D. Rybalkin, C. Yan, K.E. Bornfeldt, and J.A. Beavo Cyclic GMP phosphodiesterases and regulation of smooth muscle function Circ Res 93 2003 280 291 (Pubitemid 37048240)
11. E. DiCicco-Bloom, V. Lelivre, X. Zhou, W. Rodriguez, J. Tam, and J.A. Waschek Embryonic expression and multifunctional actions of the natriuretic peptides and receptors in the developing nervous system Dev Biol 271 2004 161 175 (Pubitemid 38757783)
12. M. Kuhn Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A Circ Res 93 2003 700 709 (Pubitemid 37288664)
13. Y. Komatsu, K. Nakao, S. Suga, Y. Ogawa, M. Mukoyama, and H. Arai C-type natriuretic peptide (CNP) in rats and humans Endocrinology 129 1991 1104 1106
14. T. Sudoh, N. Minamino, K. Kangawa, and H. Matsuo C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 1990 863 870 (Pubitemid 20164622)
15. T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo A new natriuretic peptide in porcine brain Nature 332 1988 78 81 (Pubitemid 18083551)
16. J.P. Herman, M.C. Langub Jr., and R.E. Watson Jr. Localization of C-type natriuretic peptide mRNA in rat hypothalamus Endocrinology 133 1993 1903 1906 (Pubitemid 23295225)
17. L.R. Potter, A.R. Yoder, D.R. Flora, L.K. Antos, and D.M. Dickey Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications Handb Exp Pharmacol 191 2009 341 366
18. M. Kuhn Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases Handb Exp Pharmacol 191 2009 47 69
19. F. Hofmann, D. Bernhard, R. Lukowski, and P. Weinmeister cGMP regulated protein kinases (cGK) Handb Exp Pharmacol 191 2009 137 162
20. T. Kleppisch Phosphodiesterases in the central nervous system Handb Exp Pharmacol 191 2009 71 92
21. T. Kleppisch, and R. Feil cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour Handb Exp Pharmacol 191 2009 549 759
22. D.J. Schlichter, J.E. Casnellie, and P. Greengard An endogenous substrate for cGMP-dependent protein kinase in mammalian cerebellum Nature 273 1978 61 62 (Pubitemid 8312148)
23. D.J. Schlichter, J.A. Detre, D.W. Aswad, B. Chehrazi, and P. Greengard Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum Proc Natl Acad Sci USA 77 1980 5537 5541 (Pubitemid 11249680)
24. D.W. Aswad, and P. Greengard A specific substrate from rabbit cerebellum for guanosine 3′:5′-monophosphate-dependent protein kinase. I. Purification and characterization J Biol Chem 256 1981 3487 3493 (Pubitemid 11082516)
25. D.W. Aswad, and P. Greengard A specific substrate from rabbit cerebellum for guanosine 3′:5′-monophosphate-dependent protein kinase. II. Kinetic studies on its phosphorylation by guanosine 3′:5′- monophosphate-dependent and adenosine 3′:5′-monophosphate-dependent protein kinases J Biol Chem 256 1981 3494 3500 (Pubitemid 11082517)
26. A. Aitken, T. Bilham, P. Cohen, D. Aswad, and P. Greengard A specific substrate from rabbit cerebellum for guanosine-3′:5′- monophosphate-dependent protein kinase. III. Amino acid sequences at the two phosphorylation sites J Biol Chem 256 1981 3501 3506
27. A.C. Nairn, and P. Greengard Cyclic GMP-dependent protein phosphorylation in mammalian brain Fed Proc 42 1983 3107 3113 (Pubitemid 14227561)
28. S. Endo, M. Suzuki, M. Sumi, A.C. Nairn, R. Morita, and K. Yamakawa Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells Proc Natl Acad Sci USA 96 1999 2467 2472 (Pubitemid 29117939)
29. S. Endo, A.C. Nairn, P. Greengard, and M. Ito Thr123 of rat G-substrate contributes to its action as a protein phosphatase inhibitor Neurosci Res 45 2003 79 89 (Pubitemid 36044472)
30. S. Endo, F. Shutoh, T.L. Dinh, T. Okamoto, T. Ikeda, and M. Suzuki Dual involvement of G-substrate in motor learning revealed by gene deletion Proc Natl Acad Sci USA 106 2009 3525 3530
31. K.U. Hall, S.P. Collins, D.M. Gamm, E. Massa, A.A. DePaoli-Roach, and M.D. Uhler Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate. A Purkinje cell substrate of the cyclic GMP-dependent protein kinase J Biol Chem 274 1999 3485 3495 (Pubitemid 29077189)
32. T. Nakazawa, S. Endo, M. Shimura, M. Kondo, S. Ueno, and M. Tamai Retinal G-substrate, potential downstream component of NO/cGMP/PKG pathway, is located in subtype of retinal ganglion cells and amacrine cells with protein phosphatases Brain Res Mol Brain Res 135 2005 58 68 (Pubitemid 40602399)
33. T. Nakazawa, M. Shimura, R. Mourin, M. Kondo, S. Yokokura, and T.C. Saido Calpain-mediated degradation of G-substrate plays a critical role in retinal excitotoxicity for amacrine cells J Neurosci Res 87 2009 1412 1423
34. C.Y. Chung, J.B. Koprich, S. Endo, and O. Isacson An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease J Neurosci 27 2007 8314 8323 (Pubitemid 47219631)
35. J.F. Kuo, and P. Greengard Cyclic nucleotide-dependent protein kinases. VI. Isolation and partial purification of a protein kinase activated by guanosine 3′,5′-monophosphate J Biol Chem 245 1970 2493 2498
36. G.N. Gill, G.M. Walton, and P.J. Sperry Guanosine 3′:5′- monophosphate-dependent protein kinase from bovine lung. Subunit structure and characterization of the purified enzyme J Biol Chem 252 1997 6443 6449
37. T.M. Lincoln, W.L. Dills Jr., and J.D. Corbin Purification and subunit composition of guanosine 3′:5′-monophosphate-dependent protein kinase from bovine lung J Biol Chem 252 1977 4269 4275 (Pubitemid 8114451)
38. S.H. Snyder Nitric oxide: first in a new class of neurotransmitters Science 257 1992 494 496
39. J.R. Stone, and M.A. Marletta Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states Biochemistry 33 1994 5636 5640 (Pubitemid 24163003)
40. S.R. Jaffrey, and S.H. Snyder Nitric oxide: a neural messenger Annu Rev Cell Dev Biol 11 1995 417 440 (Pubitemid 26019610)
41. A.Y. Kots, E. Martin, I.G. Sharina, and F. Murad A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases Handb Exp Pharmacol 191 2009 1 14
42. 2 + spikes in distal dendrites of CA1 pyramidal neurons Neuron 56 2007 1076 1089 (Pubitemid 350251121)
43. M.F. Nolan, G. Malleret, J.T. Dudman, D.L. Buhl, B. Santoro, and E. Gibbs A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons Cell 119 2004 719 732 (Pubitemid 39535758)
44. G.W. Wilson, and J. Garthwaite Hyperpolarization-activated ion channels as targets for nitric oxide signalling in deep cerebellar nuclei Eur J Neurosci 31 2010 1935 1945
45. C.J. Barnstable, J.Y. Wei, and M.H. Han Modulation of synaptic function by cGMP and cGMP-gated cation channels Neurochem Int 45 2004 875 884 (Pubitemid 39108060)
46. M. Biel, and S. Michalakis Cyclic nucleotide-gated channels Handb Exp Pharmacol 191 2009 111 136
47. C. Wahl-Schott, and M. Biel HCN channels: structure, cellular regulation and physiological function Cell Mol Life Sci 66 2009 470 494
48. S.H. Francis, J.D. Corbin, and E. Bischoff Cyclic GMP-hydrolyzing phosphodiesterases Handb Exp Pharmacol 191 2009 367 408
49. O.A. Reneerkens, K. Rutten, H.W. Steinbusch, A. Blokland, and J. Prickaerts Selective phosphodiesterase inhibitors: a promising target for cognition enhancement Psychopharmacology (Berl) 202 2009 419 443
50. G.S. Baillie Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases FEBS J 276 2009 1790 1799
51. J.E. Schultz Structural and biochemical aspects of tandem GAF domains Handb Exp Pharmacol 191 2009 93 109
52. R. Zoraghi, J.D. Corbin, and S.H. Francis Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins Mol Pharmacol 65 2004 267 278 (Pubitemid 38134253)
53. A. Blokland, R. Schreiber, and J. Prickaerts Improving memory: a role for phosphodiesterases Curr Pharm Des 12 2006 2511 2523
54. L.A. Miglietta, and D.L. Nelson A novel cGMP-dependent protein kinase from Paramecium J Biol Chem 263 1988 16096 161605
55. S. Klumpp, A.L. Steiner, and J.E. Schultz Immunocytochemical localization of cyclic GMP, cGMP-dependent protein kinase, calmodulin and calcineurin in Paramecium tetraurelia Eur J Cell Biol 32 1983 164 170
56. S.H. Francis, and J.D. Corbin Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action Crit Rev Clin Lab Sci 36 1999 275 328 (Pubitemid 29431414)
57. A. Pfeifer, P. Ruth, W. Dostmann, M. Sausbier, P. Klatt, and F. Hofmann Structure and function of cGMP-dependent protein kinases Rev Physiol Biochem Pharmacol 135 1999 105 149
58. A.B. Vaandrager, E.M. Ehlert, T. Jarchau, S.M. Lohmann, and H.R. de Jonge N-terminal myristoylation is required for membrane localization of cGMP-dependent protein kinase type II J Biol Chem 271 1996 7025 7029
59. S. Ono, Y. Ezura, M. Emi, Y. Fujita, D. Takada, and K. Sato A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia J Hum Genet 48 2003 447 450 (Pubitemid 37295599)
60. M.B. Soares, M.F. Bonaldo, P. Jelene, L. Su, L. Lawton, and A. Efstratiadis Construction and characterization of a normalized cDNA library Proc Natl Acad Sci USA 91 1994 9228 9232 (Pubitemid 24297887)
61. A.J. Jeffreys, L. Kauppi, and R. Neumann Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex Nat Genet 29 2001 217 222 (Pubitemid 32952662)
62. S. Myers, L. Bottolo, C. Freeman, G. McVean, and P. Donnelly A fine-scale map of recombination rates and hotspots across the human genome Science 310 2005 321 324 (Pubitemid 41457199)
63. J. Freudenberg, Y.H. Fu, and L.J. Ptácek Enrichment of HapMap recombination hotspot predictions around human nervous system genes: evidence for positive selection? Eur J Hum Genet 15 2007 1071 1078 (Pubitemid 47500012)
64. J. Freudenberg, Y.H. Fu, and L.J. Ptácek Human recombination rates are increased around accelerated conserved regions - evidence for continued selection? Bioinformatics 23 2007 1441 1443 (Pubitemid 47248457)
65. U. Landmesser, B. Hornig, and H. Drexler Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions Semin Thromb Hemost 26 2000 529 537
66. M. Francois, and G. Kojda Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway Neurochem Int 45 2004 955 961 (Pubitemid 39108068)
67. T. Münzel, A. Daiber, V. Ullrich, and A. Mülsch Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase Arterioscler Thromb Vasc Biol 25 2005 1551 1557 (Pubitemid 41098921)
68. J.C. Sowden, K. Morrison, W. Putt, R. Beddington, and Y.H. Edwards The identification of novel sequences expressed in the mouse notochord Mamm Genome 8 1997 42 44 (Pubitemid 28060742)
69. J. Altman, and S.A. Bayer Time of origin and distribution of a new cell type in the rat cerebellar cortex Exp Brain Res 29 1977 265 274 (Pubitemid 8182294)
70. J. Altman, and S.A. Bayer Prenatal development of the cerebellar system in the rat. II. Cytogenesis and histogenesis of the inferior olive, pontine gray, and the precerebellar reticular nuclei J Comp Neurol 179 1978 49 75 (Pubitemid 8373200)
71. J. Altman, and S.A. Bayer Prenatal development of the cerebellar system in the rat. I. Cytogenesis and histogenesis of the deep nuclei and the cortex of the cerebellum J Comp Neurol 179 1978 23 48 (Pubitemid 8373199)
72. J. Altman, and S.A. Bayer Embryonic development of the rat cerebellum. II. Translocation and regional distribution of the deep neurons J Comp Neurol 231 1985 27 41 (Pubitemid 15199484)
73. J. Altman, and S.A. Bayer Embryonic development of the rat cerebellum. I. Delineation of the cerebellar primordium and early cell movements J Comp Neurol 231 1985 1 26 (Pubitemid 15199483)
74. R. Iida, T. Yasuda, E. Tsubota, H. Takatsuka, M. Masuyama, and T. Matsuki Five age-dependently expressed genes in mouse brain revealed by the fluorescence differential display-PCR technique Exp Gerontol 37 2002 1121 1126
75. M. Ito Cerebellar long-term depression: characterization, signal transduction, and functional roles Physiol Rev 81 2001 1143 1195 (Pubitemid 32606668)
76. M. Ito The molecular organization of cerebellar long-term depression Nat Rev Neurosci 3 2002 896 902 (Pubitemid 135706707)
77. M. Ito Cerebellar circuitry as a neuronal machine Progr Neurobiol 78 2006 272 303 (Pubitemid 43850094)
78. J.K. Duong, K. Gardner, and L.M. Rucker Development and retention of fine psychomotor skills: implications for the aging dentist J Can Dent Assoc 76 2010 a25
79. R.D. Seidler, J.A. Bernard, T.B. Burutolu, B.W. Fling, M.T. Gordon, and J.T. Gwin Motor control and aging: links to age-related brain structural, functional, and biochemical effects Neurosci Biobehav Rev 34 2010 721 733
80. E. Scherder, W. Dekker, and L. Eggermont Higher-level hand motor function in aging and (preclinical) dementia: its relationship with (instrumental) activities of daily life - a mini-review Gerontology 54 2008 333 341
81. F.S. Menniti, W.S. Faraci, and C.J. Schmidt Phosphodiesterases in the CNS: targets for drug development Nat Rev Drug Discov 5 2006 660 670 (Pubitemid 44151604)
82. J.A. Siuciak The role of phosphodiesterases in schizophrenia: therapeutic implications CNS Drugs 22 2008 983 993
83. C. Montoliu, R. Rodrigo, P. Monfort, M. Llansola, O. Cauli, and J. Boix Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications Metab Brain Dis 25 2010 39 48
84. V. Palit, and I. Eardley An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction Nat Rev Urol 7 2010 603 609
85. H.T. Orr, M.Y. Chung, S. Banfi, T.J. Kwiatkowski Jr., A. Servadio, and A.L. Beaudet Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 Nat Genet 4 1993 221 226 (Pubitemid 23205168)
86. H.Y. Zoghbi, and H.T. Orr Glutamine repeats and neurodegeneration Ann Rev Neurosci 23 2000 217 247 (Pubitemid 30350043)
87. A. Servadio, B. Koshy, D. Armstrong, B. Antalffy, H.T. Orr, and H.Y. Zoghbi Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals Nat Genet 10 1995 94 98
88. E.N. Burright, H.B. Clark, A. Servadio, T. Matilla, R.M. Feddersen, and W.S. Yunis SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat Cell 82 1995 937 948
89. H.B. Clark, E.N. Burright, W.S. Yunis, S. Larson, C. Wilcox, and B. Hartman Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations J Neurosci 17 1997 7385 7395 (Pubitemid 27413269)
90. P.J. Skinner, C.A. Vierra-Green, H.B. Clark, H.Y. Zoghbi, and H.T. Orr Altered trafficking of membrane proteins in purkinje cells of SCA1 transgenic mice Am J Pathol 159 2001 905 913 (Pubitemid 32847181)
91. I.A. Klement, P.J. Skinner, M.D. Kaytor, H. Yi, S.M. Hersch, and H.B. Clark Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice Cell 95 1998 41 53 (Pubitemid 28458023)
92. H.G. Serra, C.E. Byam, J.D. Lande, S.K. Tousey, H.Y. Zoghbi, and H.T. Orr Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice Hum Mol Genet 13 2004 2535 2543 (Pubitemid 39377856)
93. PP2A . Two potent protein phosphatase 2A-specific inhibitor proteins Methods Mol Biol 93 1998 59 66
94. M. Li, H. Guo, and Z. Damuni Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney Biochemistry 34 1995 1988 1996
95. A. Matilla, and M. Radrizzani The Anp32 family of proteins containing leucine-rich repeats Cerebellum 4 2005 7 18 (Pubitemid 40592803)
96. I.E. Gallouzi, and J.A. Steitz Delineation of mRNA export pathways by the use of cell-permeable peptides Science 294 2001 1895 1901 (Pubitemid 33101580)
97. C.M. Brennan, I.E. Gallouzi, and J.A. Steitz Protein ligands to HuR modulate its interaction with target mRNAs in vivo J Cell Biol 151 2000 1 14
98. T. Kurihara, R.M. Lewis, J. Eisler, and P. Greengard Cloning of cDNA for DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein J Neurosci 8 1988 508 517 (Pubitemid 18078078)
99. M.E. Ehrlich, T. Kurihara, and P. Greengard Rat DARPP-32: cloning, sequencing, and characterization of the cDNA J Mol Neurosci 2 1990 1 10
100. A. Elbrecht, J. DiRenzo, R.G. Smith, and S. Shenolikar Molecular cloning of protein phosphatase inhibitor-1 and its expression in rat and rabbit tissues J Biol Chem 265 1990 13415 13418
101. S. Endo, X. Zhou, J. Connor, B. Wang, and S. Shenolikar Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor Biochemistry 35 1996 5220 5228 (Pubitemid 26129461)
102. 2 + -dependent enzyme impairs its regulation by inhibitor 1 Biochemistry 36 1997 6986 6992 (Pubitemid 27258111)
103. H.B. Huang, A. Horiuchi, T. Watanabe, S.R. Shih, H.J. Tsay, and H.C. Li Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2 J Biol Chem 274 1999 7870 7878
104. Y.G. Kwon, H.B. Huang, F. Desdouits, J.A. Girault, P. Greengard, and A.C. Nairn Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins Proc Natl Acad Sci USA 94 1997 3536 3541 (Pubitemid 27180407)
105. M.P. Egloff, D.F. Johnson, G. Moorhead, P.T. Cohen, P. Cohen, and D. Barford Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1 EMBO J 16 1997 1876 1887 (Pubitemid 27170949)
106. J.A. Detre, A.C. Nairn, D.W. Aswad, and P. Greengard Localization in mammalian brain of G-substrate, a specific substrate for guanosine 3′, 5′-cyclic monophosphate-dependent protein kinase J Neurosci 4 1984 2843 2849 (Pubitemid 15224428)
107. A. Lange, R.E. Mills, C.J. Lange, M. Stewart, S.E. Devine, and A.H. Corbett Classical nuclear localization signals: definition, function, and interaction with importin alpha J Biol Chem 282 2007 5101 5105 (Pubitemid 47093710)
108. M. Fornerod, M. Ohno, M. Yoshida, and I.W. Mattaj CRM1 is an export receptor for leucine-rich nuclear export signals Cell 90 1997 1051 1060 (Pubitemid 27408519)
109. Y. Qian, D.S. Chao, D.R. Santillano, T.L. Cornwell, A.C. Nairn, and P. Greengard cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons J Neurosci 16 1996 3130 3138 (Pubitemid 26142349)
110. J.B. Kelley, K.L. Anderson, and Y. Itzhak Pharmacological modulators of nitric oxide signaling and contextual fear conditioning in mice Psychopharmacology (Berl) 210 2010 65 74
111. K.T. Ota, V.J. Pierre, J.E. Ploski, K. Queen, and G.E. Schafe The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase Learn Mem 15 2008 792 805
112. K.T. Ota, M.S. Monsey, M.S. Wu, G.J. Young, and G.E. Schafe Synaptic plasticity and NO-cGMP-PKG signaling coordinately regulate ERK-driven gene expression in the lateral amygdala and in the auditory thalamus following Pavlovian fear conditioning Learn Mem 17 2010 221 235
113. C. Paul, F. Schöberl, P. Weinmeister, V. Micale, C.T. Wotjak, and F. Hofmann Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation J Neurosci 28 2008 14202 14212
114. A. Eskin, J.S. Takahashi, M. Zatz, and G.D. Block Cyclic guanosine 3′:5′-monophosphate mimics the effects of light on a circadian pacemaker in the eye of aplysia J Neurosci 4 1984 2466 2471 (Pubitemid 14024568)
115. D.A. Golombek, P.V. Agostino, S.A. Plano, and G.A. Ferreyra Signaling in the mammalian circadian clock: the NO/cGMP pathway Neurochem Int 45 2004 929 936 (Pubitemid 39108065)
116. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
117. N.A. Hartell, S. Furuya, S. Jacoby, and D. Okada Intercellular action of nitric oxide increases cGMP in cerebellar Purkinje cells Neuroreport 12 2001 25 28 (Pubitemid 32099021)
118. F. Crepel, and D. Jaillard Protein kinases, nitric oxide and long-term depression of synapses in the cerebellum Neuroreport 1 1990 133 136
119. M. Ito, and L. Karachot Messengers mediating long-term desensitization in cerebellar Purkinje cells Neuroreport 1 1990 129 132
120. K. Shibuki, and D. Okada Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum Nature 349 1991 326 328 (Pubitemid 21912074)
121. H. Daniel, N. Hemart, D. Jaillard, and F. Crepel Long-term depression requires nitric oxide and guanosine 3′:5′ cyclic monophosphate production in rat cerebellar Purkinje cells Eur J Neurosci 5 1993 1079 1082 (Pubitemid 23239794)
122. V. Lev-Ram, Z. Nebyelul, M.H. Ellisman, P.L. Huang, and R.Y. Tsien Absence of cerebellar long-term depression in mice lacking neuronal nitric oxide synthase Learn Mem 4 1997 169 177 (Pubitemid 27274702)
123. A.R. Boxall, and J. Garthwaite Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase Eur J Neurosci 8 1996 2209 2212 (Pubitemid 26345795)
124. S. Jacoby, R.E. Sims, and N.A. Hartell Nitric oxide is required for the induction and heterosynaptic spread of long-term potentiation in rat cerebellar slices J Physiol (Lond) 535 2001 825 839 (Pubitemid 32894492)
125. R. Feil, J. Hartmann, C. Luo, W. Wolfsgruber, K. Schilling, and S. Feil Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I J Cell Biol 163 2003 295 302 (Pubitemid 37363130)
126. J.H. Shin, and D.J. Linden An NMDA receptor/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal J Neurophysiol 94 2005 4281 4289 (Pubitemid 41691785)
127. M. Ito The cerebellum and neural control 1984 Raven Press New York
128. M. Ito The cerebellum: Brain for an implicit self 2011 FT Press New Jersey
129. D.J. Linden, and J.A. Connor Long-term depression of glutamate currents in cultured cerebellar Purkinje neurons does not require nitric oxide signaling Eur J Neurosci 4 1992 10 15
130. J.H. Shin, and D.J. Linden An NMDA receptor/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal J Neurophysiol 94 2005 4281 4289 (Pubitemid 41691785)
131. T. Launey, S. Endo, R. Sakai, J. Harano, and M. Ito Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor Proc Natl Acad Sci USA 101 2004 676 681 (Pubitemid 38084696)
132. M. Eto, R. Bock, D.L. Brautigan, and D.J. Linden Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor Neuron 36 2002 1145 1158 (Pubitemid 36044514)
133. P.F. Chapman, C.M. Atkins, M.T. Allen, J.E. Haley, and J.E. Steinmetz Inhibition of nitric oxide synthesis impairs two different forms of learning Neuroreport 3 1992 567 570
134. D. Yanagihara, and I. Kondo Nitric oxide plays a key role in adaptive control of locomotion in cat Proc Natl Acad Sci USA 93 1996 13292 13297 (Pubitemid 26382809)
135. T. Sakamoto, and S. Endo Amygdala, deep cerebellar nuclei and red nucleus contribute to delay eyeblink conditioning in C57BL/6 mice Eur J Neurosci 32 2010 1537 1551
136. H.J. Boele, S.K. Koekkoek, and C.I. De Zeeuw Cerebellar and extracerebellar involvement in mouse eyeblink conditioning: the ACDC model Front Cell Neurosci 3 2010 19
137. S. Nagao, and M. Ito Subdural application of hemoglobin to the cerebellum blocks vestibuloocular reflex adaptation Neuroreport 2 1991 193 196
138. A. Katoh, H. Kitazawa, S. Itohara, and S. Nagao Inhibition of nitric oxide synthesis and gene knockout of neuronal nitric oxide synthase impaired adaptation of mouse optokinetic response eye movements Learn Mem 7 2000 220 226 (Pubitemid 30637901)
139. F. Shutoh, M. Ohki, H. Kitazawa, S. Itohara, and S. Nagao Memory trace of motor learning shifts transsynaptically from cerebellar cortex to nuclei for consolidation Neuroscience 139 2006 767 777
140. C.D. Kassardjian, Y.F. Tan, J.Y. Chung, R. Heskin, M.J. Peterson, and D.M. Broussard The site of a motor memory shifts with consolidation J Neurosci 25 2005 7979 7985 (Pubitemid 41254400)
141. J.S. Bae, S. Furuya, Y. Shinoda, S. Endo, E.H. Schuchman, and Y. Hirabayashi Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice Hum Gene Ther 16 2005 1006 1011 (Pubitemid 41153869)
142. K. Wada, J.T. Howard, P. McConnell, O. Whitney, T. Lints, and M.V. Rivas A molecular neuroethological approach for identifying and characterizing a cascade of behaviorally regulated genes Proc Natl Acad Sci USA 103 2006 15212 15217 (Pubitemid 44583190)
143. E.D. Jarvis Learned birdsong and the neurobiology of human language Ann N Y Acad Sci 1016 2004 749 777 (Pubitemid 38951495)
144. M. Konishi Birdsong: from behavior to neuron Annu Rev Neurosci 8 1985 125 170 (Pubitemid 15137169)
145. E. Hirsch, A.M. Graybiel, and Y.A. Agid Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease Nature 334 1988 345 348
146. D.C. German, M. Dubach, S. Askari, S.G. Speciale, and D.M. Bowden 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24 1988 161 174 (Pubitemid 18044250)
147. M. Rodriguez, P. Barroso-Chinea, P. Abdala, J. Obeso, and T. González-Hernández Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease Exp Neurol 169 2001 163 181 (Pubitemid 32424333)
148. J. Grimm, A. Mueller, F. Hefti, and A. Rosenthal Molecular basis for catecholaminergic neuron diversity Proc Natl Acad Sci USA 101 2004 13891 13896 (Pubitemid 39298503)
149. C.Y. Chung, H. Seo, K.C. Sonntag, A. Brooks, L. Lin, and O. Isacson Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum Mol Genet 14 2005 1709 1725 (Pubitemid 41418045)
150. J.G. Greene, R. Dingledine, and J.T. Greenamyre Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism Neurobiol Dis 18 2005 19 31 (Pubitemid 40092894)
151. K. Lechward, O.S. Awotunde, W. Swiatek, and G. Muszyńska Protein phosphatase2A: variety of forms and diversity of functions Acta Biochim Pol 48 2001 921 933 (Pubitemid 33602348)
152. K.S. Ha, K.M. Kim, Y.G. Kwon, S.K. Bai, W.D. Nam, and Y.M. Yoo Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation FASEB J 17 2003 1036 1047
153. S. Kashii, M. Mandai, M. Kikuchi, Y. Honda, Y. Tamura, and K. Kaneda Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons Brain Res 711 1996 93 101 (Pubitemid 26081841)
154. A.H. Neufeld, A. Sawada, and B. Becker Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma Proc Natl Acad Sci USA 96 1999 9944 9948 (Pubitemid 29398837)
155. F. Sennlaub, Y. Courtois, and O. Goureau Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy J Neurosci 22 2002 3987 3993 (Pubitemid 37465707)
156. C.K. Vorwerk, B.T. Hyman, J.W. Miller, D. Husain, D. Zurakowski, and P.L. Huang The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity Invest Ophthalmol Vis Sci 38 1997 2038 2044 (Pubitemid 27407522)
157. S. Resnikoff, D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, and G.P. Pokharel Global data on visual impairment in the year 2002 Bull World Health Organ 82 2004 844 851 (Pubitemid 39573742)
158. P.A. Campochiaro Ocular neovascularisation and excessive vascular permeability Expert Opin Biol Ther 4 2004 1395 1402 (Pubitemid 39222973)
159. D. Skondra, K. Noda, L. Almulki, F. Tayyari, S. Frimmel, and T. Nakazawa Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown Invest Ophthalmol Vis Sci 49 2008 726 731
160. J. Ambati, K.V. Chalam, D.K. Chawla, C.T. D'Angio, E.G. Guillet, and S.J. Rose Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy Arch Ophthalmol 115 1997 1161 1166 (Pubitemid 27387953)
161. J. Deng, D.Z. Wu, and R. Gao Detection of glutamate and gamma-aminobutyric acid in vitreous of patients with proliferative diabetic retinopathy Yan Ke Xue Bao 16 2000 199 202
162. T.T. Lam, A.S. Abler, J.M. Kwong, and M.O. Tso N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina Invest Ophthalmol Vis Sci 40 1999 2391 2397 (Pubitemid 29418396)
163. N. Kido, H. Tanihara, M. Honjo, M. Inatani, T. Tatsuno, and C. Nakayama Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death Brain Res 884 2000 59 67
164. J.M. Kwong, and T.T. Lam N-methyl-D-aspartate (NMDA) induced apoptosis in adult rabbit retinas Exp Eye Res 71 2000 437 444
165. Y. Kitaoka, Y. Kitaoka, T. Kumai, T.T. Lam, K. Kuribayashi, and K. Isenoumi Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina Brain Res 1018 2004 111 118 (Pubitemid 38942868)
166. T. Nakazawa, M. Shimura, S. Endo, H. Takahashi, N. Mori, and M. Tamai N-Methyl-D-Aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells Mol Vis 11 2005 1173 1182 (Pubitemid 43020064)
167. M.A. MacNeil, and R.H. Masland Extreme diversity among amacrine cells: implications for function Neuron 20 1998 971 982 (Pubitemid 28247402)
168. C.M. Araki, and D.E. Hamassaki-Britto Calretinin co-localizes with the NMDA receptor subunit NR1 in cholinergic amacrine cells of the rat retina Brain Res 869 2000 220 224 (Pubitemid 30345794)
169. K.U. Domek-Łopacińska, and J.B. Strosznajder Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease Mol Neurobiol 41 2010 129 137
170. L.J. Kriegsfeld, M.J. Eliasson, G.E. Demas, S. Blackshaw, T.M. Dawson, and R.J. Nelson Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice Neuroscience 89 1999 311 315 (Pubitemid 29044314)